Effects of atorvastatin on the regeneration of pancreatic β-cells after streptozotocin treatment in the neonatal rodent

American Journal of Physiology - Endocrinology and Metabolism

Volumn 299, Issue 1, 2010, Pages

  Marchand, K C ^a,b   Arany, E J ^a,b   Hill, D J ^a,b  

^a LAWSON HEALTH RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

Endothelial cells; Regeneration

Indexed keywords

ATORVASTATIN; STREPTOZOCIN;

ANGIOGENESIS; ARTICLE; CELL GROWTH; CELL REGENERATION; CONTROLLED STUDY; DNA SYNTHESIS; ENDOTHELIUM CELL; GLUCOSE TOLERANCE; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; RAT; RODENT;

ANIMALS; ANIMALS, NEWBORN; BODY WEIGHT; DIABETES MELLITUS, EXPERIMENTAL; FEMALE; GLUCOSE TOLERANCE TEST; HEPTANOIC ACIDS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; IMMUNOHISTOCHEMISTRY; INSULIN; INSULIN-SECRETING CELLS; MALE; NEOVASCULARIZATION, PHYSIOLOGIC; ORGAN SIZE; PREGNANCY; PYRROLES; RATS; RATS, WISTAR;

EID: 77953381883     PISSN: 01931849     EISSN: 15221555     Source Type: Journal    
DOI: 10.1152/ajpendo.00132.2010     Document Type: Article

References (49)

1. Aguayo-Mazzucato C, Sanchez-Soto C, Godinez-Puig V, Gutie'rrez-Ospina G, Hiriart M. Restructuring of pancreatic islets and insulin secretion in a postnatal critical window. PLoS ONE 1: e35-42, 2006.
2. Arita S, Nagai T, Ochiai M, Sakamoto Y, Shevlin LA, Smith CV, Mullen Y. Prevention of primary nonfunction of canine islet autografts by treatment with pravastatin. Transplantation 73: 7-12, 2002.
3. Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T, Witzenbichler B, Schatteman G, Isner JM. Isolation of putative progenitor endothelial cells for angiogenesis. Science 275: 964-967, 1997. (Pubitemid 27087709)
4. Atkinson MA, Rhodes CJ. Pancreatic regeneration in type 1 diabetes: dreams on a deserted island? Diabetologia 48: 2200-2202, 2005.
5. Black AE, Hayes RN, Roth BD, Woo P, Woolf TF. Metabolism and excretion of atorvastatin in rats and dogs. Drug Metab Dispos Biol Fate Chem 27: 916-923, 1999.
6. Brand SJ, Tagerud S, Lambert P, Magil SG, Tatarkiewicz K, Doiron K, Yan Y. Pharmacological treatment of chronic diabetes by stimulating pancreatic β-cell regeneration with systemic co-administration of EGF and gastrin. Pharmacol Toxicol 91: 414-420, 2002. (Pubitemid 36132447)
7. Couri CE, Oliveira MC, Stracieri AB, Moraes DA, Pieroni F, Barros GM, Madeira MI, Malmegrim KC, Foss-Freitas MC, Simões BP, Martinez EZ, Foss MC, Burt RK, Voltarelli JC. C-peptide levels and insulin independence following autologous nonmyeloablative hematopoietic stem cell transplantation for newly diagnosed type 1 diabetes mellitus. J Am Med Assoc 301: 1573-1579, 2009.
8. Dimmeler S, Aicher A, Vasa M, Mildner-Rihm C, Adler K, Tiemann M, Rütten H, Fichtlscherer S, Martin H, Zeiher AM. HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI 3-kinase/Akt pathway. J Clin Invest 108: 91-397, 2001.
9. Dostal LA, Whitfield LR, Anderson JA. Fertility and general reproduction studies in rats with the HMG-CoA reductase inhibitor, atorvastatin. Fund Applied Toxicol 32: 285-292, 1996.
10. Dulak J, Loboda A, Jazwa A, Zagorska A, Dörler J, Alber H, Dichtl W, Weidinger F, Frick M, Jozkowicz A. Atorvastatin affects several angiogenic mediators in endothelial cells. Endothelium 12: 233-241, 2005.
11. Edelberg JM, Tang L, Hattori K, Lyden D, Rafii S. Young adult bone marrow-derived endothelial precursor cells restore aging-impaired cardiac angiogenic function. Circ Res 90: E89-E93, 2002.
12. Favaro E, Miceli I, Bussolati B, Schmitt-Ney M, Cavallo Perin P, Camussi G, Zanone MM. Hyperglycemia induces apoptosis of human pancreatic islet endothelial cells. Am J Pathol 173: 442-450, 2008.
13. Gehling UM, Ergün S, Schumacher U, Wagener C, Pantel K, Otte M, Schuch G, Schafhausen P, Mende T, Kilic N, Kluge K, Schäfer B, Hossfeld DK, Fiedler W. In vitro differentiation of endothelial cells from AC133-positive progenitor cells. Blood 95: 3106-3112, 2000.
14. Hasegawa Y, Ogihara T, Yamada T, Ishigaki Y, Imai J, Uno K, Gao J, Kaneko K, Ishihara H, Sasano H, Nakauchi H, Oka Y, Katagiri H. Bone marrow (BM) transplantation promotes β-cell regeneration after acute injury through BM cell mobilization. Endocrinology 148: 2006-2015, 2007.
15. Hattori K, Dias S, Heissig B, Hackett NR, Lyden D, Tateno M, Hicklin DJ, Zhu Z, Witte L, Crystal RG, Moore MA, Rafii S. Vascular endothelial growth factor and angiopoietin-1 stimulate postnatal hematopoiesis by recruitment of vasculogenic and hematopoietic stem cells. J Exp Med 193: 1005-1014, 2001.
16. Henck JW, Craft WR, Black A, Colgin J, Anderson JA. Pre- and postnatal toxicity of the HMG-CoA reductase inhibitor atorvastatin in rats. Toxicol Sci 41: 88-99, 1998. (Pubitemid 28201532)
17. Hess D, Li L, Sakano S, Hill DJ, Strutt B, Thyssen S, Gray D, Bhatia M. Bone marrow derived stem cells rescue hyperglycemia by regeneration of recipient islets. Nature Biotech 21: 763-770, 2003.
18. Hsu SM, Raine L, Fanger H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 29: 577-580, 1981. (Pubitemid 11147380)
19. Ianus A, Holz GG, Theise ND, Hussain MA. In vivo derivation of glucose-competent pancreatic endocrine cells from bone marrow without evidence of cell fusion. J Clin Invest 111: 843-850, 2003.
20. Johannson M, Mattsson G, Andersson A, Janson L, Carlsson PO. Islet endothelial cells and pancreatic β-cell proliferation: studies in vitro and during pregnancy in adult rats. Endocrinology 147: 2314-2324, 2006.
21. Lammert E, Cleaver O, Melton D. Role of endothelial cells in pancreas and liver development. Mech Development 120: 59-64, 2003. (Pubitemid 35462096)
22. Lechner A, Yang YG, Blacken RA, Wang L, Nolan AL, Habener JF. No evidence for significant transdifferentiation of bone marrow into pancreatic β-cells in vivo. Diabetes 53: 616-623, 2004. (Pubitemid 38270630)
23. Llevadot J, Murasawa S, Kureishi Y, Uchida S, Masuda H, Kawamoto A, Walsh K, Isner JM, Asahara T. HMG-CoA reductase inhibitor mobilizes bone marrow-derived endothelial progenitor cells. J Clin Invest 108: 399-405, 2001. (Pubitemid 32730786)
24. Lozanoska-Ochser B, Barone F, Pitzalis C, Peakman M. Atorvastatin fails to prevent the development of autoimmune diabetes despite inhibition of pathogenic β-cell-specific CD8 T-cells. Diabetes 55: 1004-1010, 2006. (Pubitemid 44100175)
25. Luo L, Luo JZ, Xiong F, Abedi M, Greer D. Cytokines inducing bone marrow SCA+ cells migration into pancreatic islet and conversion into insulin-positive cells in vitro. PLoS One 4: e4504, 2009.
26. Mattsson G, Carlsson PO, Olausson K, Jansson L. Histological markers for endothelial cells in endogenous and transplanted rodent pancreatic islets. Pancreatology 2: 155-162, 2002.
27. Nikolova G, Jabs N, Konstantinova I, Domogatskaya A, Tryggvason K, Sorokin L, Fässler R, Gu G, Gerber HP, Ferrara N, Melton DA, Lammert E. The vascular basement membrane: a niche for insulin gene expression and β cell proliferation. Dev Cell 10: 397-405, 2006.
28. Olsson R, Carlsson PO. The pancreatic islet endothelial cell: emerging roles in islet function and disease. Int J Biochem Cell Biol 38: 492-497, 2005.
29. Palomer X, Calpe-Berdiel L, Verdaguer J, Carrillo J, Pastor X, Mauricio D, Blanco-Vaca F. Atorvastatin does not decrease or delay diabetes onset in two different mouse models of type 1 diabetes. Diabetologia 48: 1671-1673, 2005. (Pubitemid 41175523)
30. Rafii S, Lyden D. Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration. Nat Med 9: 702-712, 2003. (Pubitemid 36749219)
31. Rauscher FM, Goldschmidt-Clermont PJ, Davis BH, Wang T, Gregg D, Ramaswami P, Pippen AM, Annex BH, Dong C, Taylor DA. Aging, progenitor cell exhaustion, and atherosclerosis. Circulation 108: 457-463, 2003.
32. Rosenberg L, Lipsett M, Yoon JW, Prentki M, Wang R, Jun HS, Pittenger GL, Taylor-Fishwick D, Vinik AI. A pentadecapeptide fragment of islet neogenesis-associated protein increases β-cell mass and reverses diabetes in C57BL/6J mice. Ann Surg 240: 874-884, 2004.
33. Rupp S, Badorff C, Koyanagi M, Urbich C, Fichtlscherer S, Aicher A, Zeiher AM, Dimmeler S. Statin therapy in patients with coronary artery disease improves the impaired endothelial progenitor cell differentiation into cardiomyogenic cells. Basic Res Cardiol 99: 61-68, 2004.
34. Rydgren T, Sandler S. The protective effect of simvastatin against low dose streptozotocin induced type 1 diabetes in mice is independent of inhibition of HMG-CoA reductase. Biochem Biophys Res Commun 379: 1076-1079, 2009.
35. Rydgren T, Vaarala O, Sandler S. Simvastatin protects against multiple low-dose streptozotocin-induced type 1 diabetes in CD-1 mice and recurrence of disease in non-obese diabetic mice. J Pharmacol Exper Therapeut 323: 180-185, 2007.
36. Satoh K, Keimatsu N, Kanda M, Kasai T, Takaguri A, Sun F, Ichihara K. HMG-CoA reductase inhibitors do not improve glucose intolerance in spontaneously diabetic Goto-Kakizaki rats. Biol Pharmacol Bull 28: 2092-2095, 2005.
37. Shalaby F, Rossant J, Yamaguchi TP, Gertsenstein M, Wu XF, Breitman ML, Schuh AC. Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice. Nature 376: 62-66, 1995.
38. Shi Q, Rafii S, Wu MH, Wijelath ES, Yu C, Ishida A, Fujita Y, Kothari S, Mohle R, Sauvage LR, Moore MA, Storb RF, Hammond WP. Evidence for circulating bone marrow-derived endothelial cells. Blood 92: 362-367, 1998.
39. Sordi V, Piemonti L. The contribution of hematopoietic stem cells to β-cell replacement. Curr Diab Rep 9: 119-124, 2009.
40. Suarez-Pinzon WL, Power RF, Yan Y, Wasserfall C, Atkinson M, Rabinovitch A. Combination therapy with glucagon-like peptide-1 and gastrin restores normoglycemia in diabetic NOD mice. Diabetes 57: 3281-3288, 2008.
41. Suzuki M, Kakuta H, Takahashi A, Shimano H, Tada-Iida K, Yokoo T, Kihara R, Yamada N. Effects of atorvastatin on glucose metabolism and insulin resistance in KK/Ay mice. J Atherosc Thromb 12: 77-84, 2005.
42. Taneera J, Rosengren A, Renstrom E, Nygren JM, Serup P, Rorsman P, Jacobsen SE. Failure of transplanted bone marrow cells to adopt a pancreatic β-cell fate. Diabetes 55: 290-296, 2006.
43. Thyssen S, Arany E, Hill DJ. Ontogeny of regeneration of β-cells in the neonatal rat after treatment with streptozotocin. Endocrinology 147: 2346-2356, 2006.
44. Vasa M, Fichtlscherer S, Adler K, Aicher A, Martin H, Zeiher AM, Dimmeler S. Increase in circulating endothelial progenitor cells by statin therapy in patients with stable coronary artery disease. Circulation 103: 2885-2890, 2001.
45. Xie QP, Huang H, Xu B, Dong X, Gao SL, Zhang B, Wu YL. Human bone marrow mesenchymal stem cells differentiate into insulin-producing cells upon micro-environmental manipulation in vitro. Differentiation 77: 483-491, 2009.
46. Xu G, Stoffers DA, Habener JF, Boner-Weir S. Exendin-4 stimulates both β-cell replication and neogenesis, resulting in increased β-cell mass and improved glucose tolerance in diabetic rats. Diabetes 48: 2270-2276, 2002.
47. Xu X, D'Hoker J, Stange G, Bonne S, De LN, Xiao X, Van de CM, Mellitzer G, Ling Z, Pipeleers D, Bouwens L, Scharfmann R, Gradwohl G, Heimberg H. -β-Cells can be generated from endogenous progenitors in injured adult mouse pancreas. Cell 132: 197-207, 2008.
48. Young PP, Hofling AA, Sands MS. VEGF increases engraftment of bone marrow-derived endothelial progenitor cells (EPCs) into vasculature of newborn murine recipients. Proc Nat Acad Sci USA 99: 11951-11956, 2002.
49. Zhao M, Amiel SA, Ajami S, Jiang J, Rela M, Heaton N, Huang GC. Amelioration of streptozotocin-induced diabetes in mice with cells derived from human marrow stromal cells. PLoS One 3: e2666, 2008.